Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke
Abstract In stroke patients, loss of skeletal muscle mass leads to prolonged weakness and less efficient rehabilitation. We previously showed that expression of myostatin, a master negative regulator of skeletal muscle mass, was strongly increased in skeletal muscle in a mouse model of stroke. We th...
Guardado en:
Autores principales: | Marine Maud Desgeorges, Xavier Devillard, Jérome Toutain, Josiane Castells, Didier Divoux, David Frédéric Arnould, Christopher Haqq, Myriam Bernaudin, Anne-Cécile Durieux, Omar Touzani, Damien Gilles Freyssenet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad0c911773f74bc491f220592714b3a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proteomic Studies on the Mechanism of Myostatin Regulating Cattle Skeletal Muscle Development
por: Hui Sheng, et al.
Publicado: (2021) -
Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injury
por: Christoph Wallner, et al.
Publicado: (2021) -
Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
por: Virginie Mariot, et al.
Publicado: (2017) -
A highly prevalent SINE mutation in the myostatin (MSTN) gene promoter is associated with low circulating myostatin concentration in Thoroughbred racehorses
por: Victoria O’Hara, et al.
Publicado: (2021) -
Cytotoxic aggregation and amyloid formation by the myostatin precursor protein.
por: Carlene S Starck, et al.
Publicado: (2010)